The Netherlands-based Sagility BV is likely to sell a 12% stake in healthcare services provider Sagility for approximately ₹2,377 crore through a block deal, with the floor price set at ₹42.45 per share, according to deal details. The floor price represents a discount of up to 4.9% to Sagility’s closing price of ₹44.66 on the NSE on Thursday.
The stock settled 1.4% lower in the session. Sagility BV will be subject to a 365-day lock-up on its residual stake following the transaction, according to the deal details. The proposed stake sale comes as Sagility shares have corrected more than 14% so far in 2026.
The stock currently trades at a price-to-earnings ratio of 20.33. Previous bulk and block dealsSagility has seen significant institutional activity in recent months, including a large stake sale by its promoter in November 2025. According to Trendlyne data, Sagility BV sold 76.9 crore shares at an average price of ₹47.60 apiece on the NSE on November 14, 2025.
The transaction was accompanied by purchases from several institutional investors, including Unifi Capital, Societe Generale, Norges Bank, Morgan Stanley Asia Singapore and ICICI Prudential Mutual Fund. In a separate transaction on November 21, 2025, BNP Paribas Financial Markets purchased 35 lakh shares at an average price of ₹48.23 apiece on the BSE.
Integrated Core Strategies was the seller in the transaction, according to Trendlyne data. The latest proposed transaction would mark another significant stake sale by Sagility BV.